News archive

Today test methods for immunological medicinal products are based on animal experiments. With the help of the 3R concept (replacement, reduction and refinement) application and suffering of animals in experiments required by law can be reduced or avoided completely.

The German Federal Institute of Drugs and Medical Devices (BfArM) has approved an animal-free procedure for testing of Allergan´s botulinum products.

A Berlin researcher cooperative succeeded in clarifying functional details of the dynamin molecule.

American scientists led by Jian Feng from the State University of New York at Buffalo have transformed skin cells of patients who are suffering from Parkinson´s into induced pluripotent stem cells (iPS) an than into nerve cells.

Call for submission: EPAA SCIENCE AWARD 2012

Wednesday, 01 February 2012 10:06

The European Partnership for Alternative Approaches to Animal Testing (EPAA), a cooperation between the European Commission and industry from various sectors, is organising for the second time its Science Award, worth up to 100 000 €.

As a first graduate of the MSc course "miniaturized biotechnology", offered by the Department of Mediocal Technology and Biotechnology of the University of Applied Sciences Jena, in her final studies a student developed a new method for microfluidic cultivation of cells.

American scientists headed by Janet Tse at the Massachusetts Institute of Technology (MIT) in Cambridge exposed different breast cancer cell lines to different pressures. They found out that these breast cancer cells penetrate into surrounding healthy tissue and can therefore promote the spread of cancer.

Stem cells detected in the retina

Friday, 06 January 2012 10:48

American scientists have detected a previously unknown type of stem cells in the retina of the human eye.

Each year the Körber Foundation presents the German Thesis Award for the year’s most important dissertations. Applications can be submitted until 1 March 2012.

Researchers at the Fraunhofer Research Institution for Modular Solid State Technologies (EMFT), Munich, have developed a new approach using sensor nanoparticles for the purpose of testing the effects and potential risks of substances in cell cultures.